| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,246,719 | 1,108,755 | 1,019,817 | 1,133,735 | | Cost of Revenue | 1,034,698 | 917,640 | 837,163 | 946,683 | | | Gross Profit | 212,021 | 191,115 | 182,654 | 187,052 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 162,466 | 151,113 | 153,234 | 159,822 | | Non Recurring | 702 | 2,135 |
-
| 114,937 | | Others | 6,666 | 6,367 | 6,508 | 6,603 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 42,187 | 31,500 | 22,912 | (94,310) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 594 | 227 | 7,384 | 35,754 | | Earnings Before Interest And Taxes | 42,781 | 31,727 | 30,296 | (58,556) | | Interest Expense | 14,841 | 15,433 | 15,925 | 17,554 | | Income Before Tax | 27,940 | 16,294 | 14,371 | (76,110) | | Income Tax Expense | 9,600 | 6,212 | 5,996 | (31,596) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,340 | 10,082 | 8,375 | (44,514) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,340 | 10,082 | 8,375 | (44,514) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,340 | $10,082 | $8,375 | ($44,514) |
|
1.52% Nasdaq 
Income Statement
